1 |
Citera G, Arias MA, Maldonado-Cocco JA, et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 2000;19:9-13.
DOI
|
2 |
Hussain SA, Al-Khalifa II, Jasim NA, Gorial FI. Adjuvant use of melatonin for treatment of fibromyalgia. J Pineal Res 2011;50:267-271.
DOI
ScienceOn
|
3 |
Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2005;22:927-934.
DOI
ScienceOn
|
4 |
Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005;54:1402-1407.
DOI
ScienceOn
|
5 |
Claustrat B, Brun J, Geoffriau M, Zaidan R, Mallo C, Chazot G. Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia 1997;17:511-517.
DOI
ScienceOn
|
6 |
Peres MF, Zukerman E, da Cunha Tanuri F, Moreira FR, Cipolla- Neto J. Melatonin, 3 mg, is effective for migraine prevention. Neurology 2004;63:757.
DOI
ScienceOn
|
7 |
Zurowski D, Nowak L, Machowska A, Wordliczek J, Thor PJ. Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism. J Physiol Pharmacol 2012;63:641-647.
|
8 |
Shavali S, Ho B, Govitrapong P, et al. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 2005;64:471-479.
DOI
ScienceOn
|
9 |
Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev 2007;59:825-827.
DOI
ScienceOn
|
10 |
Kalsbeek A, Palm IF, La Fleur SE, et al. SCN outputs and the hypothalamic balance of life. J Biol Rhythms 2006;21:458-469.
DOI
|
11 |
Maronde E, Stehle JH. The mammalian pineal gland: known facts, unknown facets. Trends Endocrinol Metab 2007;18:142-149.
DOI
ScienceOn
|
12 |
Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987;63:30-36.
DOI
ScienceOn
|
13 |
Ulugol A, Dokmeci D, Guray G, Sapolyo N, Ozyigit F, Tamer M. Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the Larginine-NO pathway and opioid system. Life Sci 2006;78:1592-1597.
DOI
ScienceOn
|
14 |
Cermakian N, Lange T, Golombek D, et al. Crosstalk between the circadian clock circuitry and the immune system. Chronobiol Int 2013;30:870-888.
DOI
ScienceOn
|
15 |
Nakao A. Temporal regulation of cytokines by the circadian clock. J Immunol Res 2014;2014:614529.
|
16 |
Clench J, Reinberg A, Dziewanowska Z, Ghata J, Smolensky M. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur J Clin Pharmacol 1981;20:359-369.
DOI
|
17 |
Ollagnier M, Decousus H, Cherrah Y, et al. Circadian changes in the pharmacokinetics of oral ketoprofen. Clin Pharmacokinet 1987;12:367-378.
DOI
ScienceOn
|
18 |
Lemmer B, Bruguerolle B. Chronopharmacokinetics. Are they clinically relevant? Clin Pharmacokinet 1994;26:419-427.
DOI
ScienceOn
|
19 |
Perpoint B, Mismetti P, Simitsidis S, et al. Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis. Chronobiol Int 1994;11:119-125.
DOI
|
20 |
Moore JG, Goo RH. Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man. Chronobiol Int 1987;4:111-116.
DOI
|
21 |
Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain 2011;152:1256-1262.
DOI
ScienceOn
|
22 |
Zimmet PZ, Wall JR, Rome R, Stimmler L, Jarrett RJ. Diurnal variation in glucose tolerance: associated changes in plasma insulin, growth hormone, and non-esterified fatty acids. Br Med J 1974;1:485-488.
DOI
|
23 |
Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev 2007;59:828-851.
DOI
ScienceOn
|
24 |
Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol Int 2002;19:461-481.
DOI
ScienceOn
|
25 |
Jarrett RJ. Circadian variation in blood glucose levels, in glucose tolerance and in plasma immunoreactive insulin levels. Acta Diabetol Lat 1972;9:263-275.
DOI
|
26 |
Smolensky MH, Portaluppi F, Manfredini R, et al. Diurnal and twenty-four hour patterning of human diseases: cardiac, vascular, and respiratory diseases, conditions, and syndromes. Sleep Med Rev 2015;21:3-11.
DOI
ScienceOn
|
27 |
Smolensky MH, Portaluppi F, Manfredini R, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev 2015;21:12-22.
DOI
ScienceOn
|
28 |
Bruguerolle B, Labrecque G. Rhythmic pattern in pain and their chronotherapy. Adv Drug Deliv Rev 2007;59:883-895.
DOI
ScienceOn
|
29 |
Frederickson RC, Burgis V, Edwards JD. Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science 1977;198:756-758.
DOI
|
30 |
Kehl LJ, Fairbanks CA. Experimental animal models of muscle pain and analgesia. Exerc Sport Sci Rev 2003;31:188-194.
DOI
|
31 |
Berge OG. Predictive validity of behavioural animal models for chronic pain. Br J Pharmacol 2011;164:1195-1206.
DOI
ScienceOn
|
32 |
Levi F, Le Louarn C, Reinberg A. Timing optimizes sustainedrelease indomethacin treatment of osteoarthritis. Clin Pharmacol Ther 1985;37:77-84.
DOI
|
33 |
Pöllmann L. Circadian changes in the duration of local anaesthesia. Int J Oral Surg 1982;11:36-39.
DOI
|
34 |
Kowanko IC, Pownall R, Knapp MS, Swannell AJ, Mahoney PG. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. Br J Clin Pharmacol 1981;11:477-484.
DOI
ScienceOn
|
35 |
Cutolo M, Masi AT. Circadian rhythms and arthritis. Rheum Dis Clin North Am 2005;31:115-129.
DOI
ScienceOn
|
36 |
Bellamy N, Sothern RB, Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. J Rheumatol 1990;17:364-372.
|
37 |
Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis 2002;61:1075-1080.
DOI
|
38 |
van Grootel RJ, van der Glas HW, Buchner R, de Leeuw JR, Passchier J. Patterns of pain variation related to myogenous temporomandibular disorders. Clin J Pain 2005;21:154-165.
DOI
ScienceOn
|
39 |
Glaros AG, Williams K, Lausten L. Diurnal variation in pain reports in temporomandibular disorder patients and control subjects. J Orofac Pain 2008;22:115-121.
|
40 |
Jensen TS, Baron R, Haanpaa M, et al. A new definition of neuropathic pain. Pain 2011;152:2204-2205.
DOI
ScienceOn
|
41 |
Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000;87:149-158.
DOI
ScienceOn
|
42 |
Odrcich M, Bailey JM, Cahill CM, Gilron I. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy. Pain 2006;120:207-212.
DOI
ScienceOn
|
43 |
Takada T, Yamashita A, Date A, et al. Changes in the circadian rhythm of mRNA expression for -opioid receptors in the periaqueductal gray under a neuropathic pain-like state. Synapse 2013;67:216-223.
DOI
ScienceOn
|
44 |
Belgrade MJ. Following the clues to neuropathic pain. Distribution and other leads reveal the cause and the treatment approach. Postgrad Med 1999;106:127-132, 135-140.
|
45 |
Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-128.
DOI
ScienceOn
|
46 |
Gilron I, Bailey JM, Vandenkerkhof EG. Chronobiological characteristics of neuropathic pain: clinical predictors of diurnal pain rhythmicity. Clin J Pain 2013;29:755-759.
DOI
|
47 |
Forssell H, Teerijoki-Oksa T, Kotiranta U, et al. Pain and pain behavior in burning mouth syndrome: a pain diary study. J Orofac Pain 2012;26:117-125.
|
48 |
Lopez-Jornet P, Molino Pagan D, Andujar Mateos P, Rodriguez Agudo C, Pons-Fuster A. Circadian rhythms variation of pain in burning mouth syndrome. Geriatr Gerontol Int 2015;15:490-495.
DOI
ScienceOn
|
49 |
Braud A, Touré B, Agbo-Godeau S, Descroix V, Boucher Y. Characteristics of pain assessed with visual analog scale and questionnaire in burning mouth syndrome patients: a pilot study. J Orofac Pain 2013;27:235-242.
|
50 |
Paterson AJ, Lamb AB, Clifford TJ, Lamey PJ. Burning mouth syndrome: the relationship between the HAD scale and parafunctional habits. J Oral Pathol Med 1995;24:289-292.
DOI
ScienceOn
|
51 |
Kho HS, Lee JS, Lee EJ, Lee JY. The effects of parafunctional habit control and topical lubricant on discomforts associated with burning mouth syndrome (BMS). Arch Gerontol Geriatr 2010;51:95-99.
DOI
ScienceOn
|
52 |
Lamey PJ, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. Br Med J (Clin Res Ed) 1988;296:1243-1246.
DOI
|
53 |
Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291.
DOI
|
54 |
Boras VV, Brailo V, Lukac J, Kordic D, Blazic-Potocki Z. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome. Oral Dis 2006;12:353-355.
DOI
ScienceOn
|
55 |
Petraglia F, Facchinetti F, Parrini D, Micieli G, De Luca S, Genazzani AR. Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. Horm Res 1983;17:147-152.
DOI
|
56 |
Pikula DL, Harris EF, Desiderio DM, Fridland GH, Lovelace JL. Methionine enkephalin-like, substance P-like, and beta-endorphin-like immunoreactivity in human parotid saliva. Arch Oral Biol 1992;37:705-709.
DOI
ScienceOn
|
57 |
Almay BG, von Knorring L, Wetterberg L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res 1987;22:179-191.
DOI
ScienceOn
|
58 |
Odo M, Koh K, Takada T, et al. Changes in circadian rhythm for mRNA expression of melatonin 1A and 1B receptors in the hypothalamus under a neuropathic pain-like state. Synapse 2014;68:153-158.
DOI
ScienceOn
|
59 |
Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 2011;51:270-277.
DOI
ScienceOn
|